))
Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Our mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer, so they can make the best decisions for their lives. Breastcancer.org podcasts offer unique insights on prevention, treatment, research, and other breast cancer topics from our medical experts and invited guests.
…
continue reading
Five patient advocates share what they like and what they’re excited about at the 2024 San Antonio Breast Cancer Symposium. The advocates are: Antoinette Greer, of My Sister My Friend Breast Cancer Support Gitte Joergensen, of the Lobular Breast Cancer Alliance Joan Mancuso, of Theresa’s Research Foundation Barbara Bigelow, of Metavivor and the MBC…
…
continue reading
The 2024 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings. Dr. Marisa Weiss, founder and chief medical officer of Breastcancer.org, breaks down the research that will have the most immediate impact for people diagnosed with breast cancer. Listen to the episode to hear Dr. …
…
continue reading
At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program and Translational Research Integration at the UCLA Health Jonsson Comprehensive Cancer Center, presented results from the DESTINY-Breast06 study, showing that Enhertu (chemical name: fam-trastuzumab deruxtecan-nxki), also called T-DXd, was be…
…
continue reading
Cases of breast cancer in young women have been increasing dramatically in the last eight years. Dr. Matteo Lambertini, whose research focuses on breast cancer in young, especially fertility and pregnancy after a breast cancer diagnosis, chaired a session on breast cancer in the young at the 2024 San Antonio Breast Cancer Symposium. He also present…
…
continue reading
Andrea Hans was diagnosed with stage II triple-negative breast cancer when she was 28. With expertise in public health and health policy, she began working as an advocate to empower young women to understand their breast cancer risk factors. Andrea received an Alamo Breast Cancer Foundation Advocate Scholarship to attend the 2024 San Antonio Breast…
…
continue reading
At the 2024 San Antonio Breast Cancer Symposium Dr. Don Dizon, professor of medicine and professor of surgery at the Brown University Cancer Institute, was part of a panel entitled “Sex, Drugs, and Rock and Roll.” His presentation focused on sexual health after breast cancer. Listen to the episode to hear Dr. Dizon discuss: the highlights of his pr…
…
continue reading
New research suggests that estrogen plays a role in allowing hormone receptor-negative breast cancer to grow. This is because estrogen limits the ability of the immune system to attack cancer cells; it also makes immunotherapy medicines, like Keytruda (chemical name: pembrolizumab), less effective. Dr. Donald McDonnell, senior author of the study, …
…
continue reading
In the THRIVE trial, sexual side effects caused by hormonal therapy led to lower mental quality of life in both Black and white women, but caused lower physical quality of life only in Black women. Sexual side effects were also linked to Black women being less likely to take hormonal therapy as prescribed, but not white women. Dr. Janeane Anderson,…
…
continue reading
Being diagnosed with breast cancer at any age is frightening and unexpected. But if you’re diagnosed in your 20s – before any type of screening starts – you face different challenges than if you’re diagnosed later in life. LaShae Rolle, who studies cancer disparities, was diagnosed with breast cancer in 2023 at age 26. When she found a lump in her …
…
continue reading
Inflammatory breast cancer is a rare and aggressive type of breast cancer; only about 1% to 5% of all breast cancers diagnosed in the United States are inflammatory. This type of breast cancer tends to be diagnosed in younger women and has very different symptoms than other types of breast cancer; it can be mistaken for an infection. Dr. Filipa Lyn…
…
continue reading
A breast cancer diagnosis is a trauma, both physically and emotionally. You may find yourself wondering why no one is calling you one day and wishing you could just be left alone the next. This podcast is the audio from a special Virtual Community Meetup featuring guest moderator Kelly Grosklags. Listen to the podcast to hear Kelly and Community me…
…
continue reading
A number of breast cancer treatments, including chemotherapy and some targeted therapy medicines, like Herceptin (trastuzumab), can cause oral side effects, including mouth sores, dry mouth and infections. Dr. Sollecito explains why these side effects happen and how they’re treated. Listen to the episode to hear Dr. Sollecito explain: why it’s a go…
…
continue reading
While preparing for breast cancer surgery and reconstruction, Erica Neubert Campbell was understandably scared and anxious. She also had no idea what her reconstructed breasts would look like. Then a colleague shared that she had been through the same experience and showed Campbell her results. The information gave Campbell hope and strength, and s…
…
continue reading
The U.S. Preventive Services Task Force updated its screening mammogram recommendations. Having a double mastectomy after being diagnosed with breast cancer in one breast doesn’t lower the risk of dying from the disease. Certain types of exercise can reduce the risk of metastatic recurrence and neuropathy caused by chemotherapy. What does all this …
…
continue reading
Certain breast cancer treatments, including the aromatase inhibitors – medicines that stop the body from making estrogen – and certain chemotherapy medicines can compromise bone health and lead to osteoporosis. Listen to the episode to hear Dr. Shahane explain: the difference between osteoporosis and osteopenia osteoporosis risk factors how osteopo…
…
continue reading
Carly Fauth was diagnosed with breast cancer in January 2024. Scheduled to start chemotherapy in May, Carly decided to start a podcast called Chemo Coffee Talk, which she records from her chemo chair during her twice-monthly infusions at the Dana-Farber Brigham Cancer Center. Listen to the episode to hear Carly discuss: how recording the podcast ta…
…
continue reading
Palliative care is often confused with hospice care, but the two are very different. This podcast is the audio from a special Virtual Community Meetup featuring guest moderator Dr. Joe Straton. Listen to the episode to hear Dr. Straton discuss: the issues palliative care addresses the difference between palliative care and hospice care the appropri…
…
continue reading
In late 2019, Meredith’s routine mammogram showed an area of concern. Both her doctor and AI – an artificial intelligence program -- read her mammogram. Her doctor looked at the images and knew she had cancer, while the AI reading wasn’t so clear. Listen to the episode to hear Meredith explain: how AI is taught to read and interpret a mammogram the…
…
continue reading
At the 2024 American Society of Clinical Oncology Annual Meeting (ASCO) in June, an entire poster session was dedicated to treatment-related side effects. Listen to the episode to hear: Dr. Miriam Klahr discuss links between high blood sugar (hyperglycemia) and chemotherapy-induced peripheral neuropathy :42-2:20 Dr. Ana Ferrigno Guajardo explain he…
…
continue reading
At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Fumiko Chino, MD, presented the results of research she conducted with Breastcancer.org on how doctors’ communication skills affected how well breast cancer patients stuck to their treatment plants. Listen to the podcast to hear Dr. Chino explain: why she wanted to do the study…
…
continue reading
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified medical oncologist at the Valley-Mount Sinai Comprehensive Cancer Center in Paramus, NJ, summarizes the top breast cancer research. Listen to the episode …
…
continue reading
Black women have a higher risk of developing triple-negative breast cancer at a young age than white women. At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Holly Pederson, of the Cleveland Clinic, and Dr. Elisha Hughes, of Myriad Genetics, presented their research on how a polygenic risk score can help predict the risk …
…
continue reading
At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Brooklyn Olumba was part of ASCO Voices, a program that gives people in the oncology a community an opportunity to tell their stories. Her talk was entitled “Genetic Testing Saved My Life.” Listen to the episode to hear Dr. Olumba explain: how she came to have genetic test…
…
continue reading
There are many reasons women don’t get annual mammograms, including the distance to a mammogram facility, lack of transportation, or not having a primary care doctor. Licensed, certified genetic counselor Rena Vanzo wants to overcome those barriers. She’s started The Boob Bus, a mobile mammography bus that also offers genetic testing and cosmetic p…
…
continue reading
Pain is a common side effect of breast cancer. The cancer itself may cause pain and nearly all breast cancer treatments may cause some type of pain. If breast cancer is metastatic – meaning it’s spread to parts of the body away from the breast, such as the bones or liver – it may cause pain in those areas. There are many medicines that can ease can…
…
continue reading
